Urdu Translation of Revised High-Level Mobility Assessment Tool (HiMAT) in Healthy Children

NCT ID: NCT06986720

Last Updated: 2025-05-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-12

Study Completion Date

2025-07-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The ability to move with ease is labelled as mobility. Limitations in mobility are frequent, recovery of these skills is crucial for physical performance which gives children valuable social possibilities and has long-term advantages for their physical and mental health. The high-level mobility assessment tool (HiMAT) is a unidimensional performance to measure the degree of high-level mobility in traumatic brain injury patients. The revised HiMAT has been utilised recently in paediatric populations to assess clinical trial outcomes and measure high-level motor skills.

Urdu translation of revised HiMAT will be executed by using forward backwards translation method. Two bilingual translators fluent in both Urdu and English languages will facilitate the researcher in the translation of the tool. This final translated version will be then tested for validity and reliability on all participants of the study. The psychometric properties of the tool will be assessed including reliability, internal consistency, and item discrimination.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Following steps will be followed for translation:

1. Forward Translation:

Two independent translators who spoke Urdu as their native language will conduct initial translation into Urdu (U-HiMAT).
2. Synthesis:

In this step both translated versions (U1 \& U2) will be synthesized to obtain a common translated version of U-HiMAT. Full Urdu version of scale will be completed.
3. Backward Translation:

Urdu translated version will be translated back into English by a different team consisting of professional independent bilingual translators.
4. Expert Committee:

Expert committees consisting of pediatric physical therapists and pediatric clinical practitioners will evaluate and review the difference between a translated version and an original draft. They will create a pre final version for field testing.
5. Pre-Final Version Testing:

Pre-final Urdu and English version of scale will be tested on patients. Expert panel will review the findings from this process.

After completion of translation process, psychometric properties of the tool will be analysed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children with age group 5-12 years
* No condition affecting mobility of children
* Able to understand and follow instruction.
* Can speak \& understand language

Exclusion Criteria

* Children with visual impairments.
* Children with conditions affecting their mobility.
* Children with any history of surgery in the past one year.
* Children with any cardiorespiratory comorbidities.
* Children with muscle strain, ligament sprain or joint laxity in lower extremities.
* Cognition less than 20 on Mini Mental State Examination (MMSE).
* Children with any history of any foot deformity
Minimum Eligible Age

5 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shazia Muheen, MS

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Riphah International University

Lahore, Punjab Province, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Imran Amjad, PhD

Role: CONTACT

+9233224390125

Muhammad Asif Javed, MS

Role: CONTACT

+923224209422

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Muhammad Asif Javed, MS

Role: primary

+923224209422

Imran Amjad, PhD

Role: backup

+9233224390125

References

Explore related publications, articles, or registry entries linked to this study.

Williams G, Pallant J, Greenwood K. Further development of the High-level Mobility Assessment Tool (HiMAT). Brain Inj. 2010;24(7-8):1027-31. doi: 10.3109/02699052.2010.490517.

Reference Type BACKGROUND
PMID: 20545456 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/RCR&AHS/24/0729

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Implementation of the Pain Management Toolkit
NCT07157709 ENROLLING_BY_INVITATION NA